Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

[3H]benzylpempidine, a new radioligand for probing a putative channel site on nicotinic cholinergic receptors.

Wang DX, Sheu SS, Sharma VK, Rubin L, Journet M, Kende AS, Abood LG.

Life Sci. 1997;60(15):1271-7.

PMID:
9096244
3.

Molecular mechanisms of the brain reward system.

Abood LG.

NIDA Res Monogr. 1996;162:34-6. No abstract available.

PMID:
9066806
4.
5.

Probing ion channels and recognition sites of neuronal nicotinic cholinergic receptors with novel nicotine affinity and other ligands.

Lerner-Marmarosh N, Kende AS, Wang DX, Abood LG.

Ann N Y Acad Sci. 1995 May 10;757:120-32. Review. No abstract available.

PMID:
7611669
6.

Diversity of interacting receptors. Background and overview of the conference.

Abood LG.

Ann N Y Acad Sci. 1995 May 10;757:1-6. Review. No abstract available.

PMID:
7611666
7.

Antagonism of nicotine's action by cocaine analogs.

Lerner-Marmarosh N, Carroll FI, Abood LG.

Life Sci. 1995;56(3):PL67-70.

PMID:
7823767
8.

Differences in ligand binding and phosphoinositide turnover between M1 muscarinic receptor gene transfected cells and mouse and rat brain membranes.

Wang DX, Lerner-Marmarosh N, Sheu SS, Sharma V, Jou MJ, Abood LG.

Pharmacol Biochem Behav. 1994 Oct;49(2):405-11.

PMID:
7824557
9.

5-Isothiocyanonicotine: a high-affinity irreversible ligand for brain nicotinic receptors.

Kim KD, Lerner-Marmarosh N, Saraswati M, Kende AS, Abood LG.

Biochem Pharmacol. 1994 Jun 1;47(11):1965-7.

PMID:
8010981
10.

Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.

Abood LG, Saraswati M, Lerner-Marmarosh N, Hashmi M.

Biochem Pharmacol. 1993 May 25;45(10):2143-8.

PMID:
8512596
11.

Opioid receptor antagonist affinity ligands: 6 beta-bromoacetamido-6-desoxynaltrexone and 6 beta-thioglycolamido-6-desoxynaltrexone.

Manda S, Lerner-Marmarosh N, Hashmi M, Abood LG.

Neurochem Res. 1992 Dec;17(12):1191-4.

PMID:
1334238
12.

4-Bromoacetamidoprocaine: an affinity ligand for brain muscarinic and nicotinic cholinergic receptors.

Saraswati M, Hashmi M, Abood LG.

Neurochem Res. 1992 Mar;17(3):247-52.

PMID:
1620268
13.

Structure-activity relationships for various N-alkylcarbamyl esters of choline with selective nicotinic cholinergic properties.

Punzi JS, Banerjee S, Abood LG.

Biochem Pharmacol. 1991 Feb 1;41(3):465-7. No abstract available.

PMID:
1994905
14.

[3H]mecamylamine binding to rat brain membranes. Studies with mecamylamine and nicotine analogues.

Banerjee S, Punzi JS, Kreilick K, Abood LG.

Biochem Pharmacol. 1990 Nov 1;40(9):2105-10.

PMID:
2242037
15.

Arginine vasopressin-anti-idiotypic immunostaining of human brain cells.

Joseph SA, Pilcher WH, Knigge KM, Abood LG, Michael GJ.

J Neuroendocrinol. 1990 Oct 1;2(5):659-65. doi: 10.1111/j.1365-2826.1990.tb00462.x.

PMID:
19215403
16.
17.

Nicotine antagonists: phosphoinositide turnover and receptor binding to determine muscarinic properties.

Benerjee S, Abood LG.

Biochem Pharmacol. 1989 Sep 1;38(17):2933-5. No abstract available.

PMID:
2550015
18.

Sites, mechanisms, and structural characteristics of the brain's nicotine receptor.

Abood LG, Banerjee S, Kanne DB.

J Subst Abuse. 1989;1(3):259-71. Review.

PMID:
7580218
19.

Immunocytochemistry of receptors using anti-idiotypic antibodies.

Knigge KM, Piekut DT, Abood LG, Joseph SA, Michael GJ, Xin L, Berlove DJ.

Methods Enzymol. 1989;178:212-21. No abstract available.

PMID:
2557524
22.
23.

Structure-activity studies of carbamate and other esters: agonists and antagonists to nicotine.

Abood LG, Shahid Salles K, Maiti A.

Pharmacol Biochem Behav. 1988 Jun;30(2):403-8.

PMID:
3174772
24.

Synthesis and biological characterization of pyridohomotropanes. Structure-activity relationships of conformationally restricted nicotinoids.

Kanne DB, Abood LG.

J Med Chem. 1988 Mar;31(3):506-9. Erratum in: J Med Chem 1988 Nov;31(11):2227.

PMID:
3346870
25.
26.

Characterization of a purified nicotinic receptor from rat brain by using idiotypic and anti-idiotypic antibodies.

Abood LG, Langone JJ, Bjercke R, Lu X, Banerjee S.

Proc Natl Acad Sci U S A. 1987 Sep;84(18):6587-90.

27.

Receptor binding characteristics of a 3H-labeled azetidine analogue of nicotine.

Abood LG, Lu X, Banerjee S.

Biochem Pharmacol. 1987 Jul 15;36(14):2337-41.

PMID:
3606644
28.

[3H]methylcarbamylcholine, a new radioligand for studying brain nicotinic receptors.

Abood LG, Grassi S.

Biochem Pharmacol. 1986 Dec 1;35(23):4199-202.

PMID:
3790148
29.
30.

Synthesis of the first highly potent bridged nicotinoid 9-Azabicyclo[4.2.1]nona[2,3-c]pyridine (pyrido[3,4-b]homotropane).

Kanne DB, Ashworth DJ, Cheng MT, Mutter LC, Abood LG.

J Am Chem Soc. 1986 Nov 1;108(24):7864-5. doi: 10.1021/ja00284a078. No abstract available.

PMID:
22283316
31.

Barrel rotation and prostration by vasopressin and nicotine in the vestibular cerebellum.

Maiti A, Shahid Salles K, Grassi S, Abood LG.

Pharmacol Biochem Behav. 1986 Sep;25(3):583-8.

PMID:
3774824
32.

Behavior and receptor changes after kainate lesioning of nodular cerebellum.

Maiti A, Shahid Salles K, Grassi S, Abood LG.

Pharmacol Biochem Behav. 1986 Sep;25(3):589-94.

PMID:
3022307
33.

Mechanism of phospholipase A2-induced conduction block in bullfrog sciatic nerve. II. Biochemistry.

Kasckow JW, Abood LG, Hoss W, Herndon RM.

Brain Res. 1986 May 14;373(1-2):392-8.

PMID:
3487370
34.

Mechanism of phospholipase A2-induced conduction block in bullfrog sciatic nerve. I. Electrophysiology and morphology.

Kasckow JW, Abood LG, Hoss W, Herndon RM.

Brain Res. 1986 May 14;373(1-2):384-91.

PMID:
3487369
35.

Two classes of arginine vasopressin binding sites on rat brain membranes.

Junig JT, Abood LG, Skrobala AM.

Neurochem Res. 1985 Sep;10(9):1187-202.

PMID:
4058655
36.
37.

Comparison of the binding of optically pure (-)- and (+)- [3H]nicotine to rat brain membranes.

Abood LG, Grassi S, Noggle HD.

Neurochem Res. 1985 Feb;10(2):259-67.

PMID:
3990894
38.

Specific binding and metabolism of (-)- and (+)-[3H]-nicotine in isolated rat hepatocytes and hepatocyte membranes.

Abood LG, Grassi S, Junig J, Crane A, Costanzo M.

Arch Int Pharmacodyn Ther. 1985 Jan;273(1):62-73.

PMID:
4004416
39.

Solubilization and characterization of muscarinic receptors from bovine brain.

Baron B, Abood LG.

Life Sci. 1984 Dec 10;35(24):2407-14.

PMID:
6513721
40.

Behavioral and biochemical studies in rats after chronic exposure to nicotine.

Abood LG, Grassi S, Costanzo M, Junig J.

NIDA Res Monogr. 1984;54:348-55. No abstract available.

PMID:
6442761
41.

Mechanisms of tolerance and dependence: an overview.

Abood LG.

NIDA Res Monogr. 1984;54:4-11. No abstract available.

PMID:
6099880
42.

14 beta-(2-bromoacetamido)morphine and 14 beta-(2-bromoacetamido)morphinone.

Archer S, Seyed-Mozaffari A, Osei-Gyimah P, Bidlack JM, Abood LG.

J Med Chem. 1983 Dec;26(12):1775-7.

PMID:
6315939
43.

Stimulation of phospholipase A2 and secretion of catecholamines from brain synaptosomes by potassium and A23187.

Bradford PG, Marinetti GV, Abood LG.

J Neurochem. 1983 Dec;41(6):1684-93.

PMID:
6139416
44.

Phencyclidine inhibition of the acetylcholine receptor: measurement of cation flux in a sympathetic neuronal cell line using 22Na+ and spectroscopic detection of Cs+.

Sachs AB, Leprince P, Karpen JW, Pasquale EB, Abood LG, Hess GP.

Arch Biochem Biophys. 1983 Sep;225(2):500-4.

PMID:
6625597
45.

Binding of optically pure (--)-[3H]nicotine to rat brain membranes.

Abood LG, Grassi S, Costanza M.

FEBS Lett. 1983 Jun 27;157(1):147-9.

46.

Isolation of a nicotine binding site from rat brain by affinity chromatography.

Abood LG, Latham W, Grassi S.

Proc Natl Acad Sci U S A. 1983 Jun;80(11):3536-9.

47.

Molecular characteristics of brain opiate and nicotine receptors.

Bidlack JM, Abood LG.

Biomembranes. 1983;11:415-37.

PMID:
6299419
49.
50.

Affinity labeling and purification of the opiate receptor from rat brain.

Bidlack JM, Abood LG, Munemitsu SM, Archer S, Gala D, Kreilick RW.

Adv Biochem Psychopharmacol. 1982;33:301-9.

PMID:
6289627

Supplemental Content

Loading ...
Support Center